000			02796nam a2200265 4500
001			395507
010			_a9789294974082
090			_a395507
100			_a20190617d2019 y0pory50 ba
101			_aeng
200			_aAn analysis of post-mortem toxicology practices in drug-related death cases in Europe _bRecurso eletrónico _etechnical report
210			_aLuxembourg _cPublications Office of the European Union _d2019
215			_a1 CD-ROM _d12 cm
300			_aFicheiro de 1,21 MB em formato PDF (52 p.).
330			_aAcknowledgements. Executive summary. Background and objectives. Key findings. Limitations. Conclusions. Introduction. Part 1: Scoping study on national reference documents that address drug-related death toxicology investigations in Europe (28 EU Member States plus Norway and Turkey). 1.1. Objective and methods. 1.2. Findings. 1.2.1. Coverage of post-mortem toxicology in national and international guidelines. 1.2.2. Decision-making on the application of post-mortem forensic toxicological investigations in suspected drug-related deaths. 1.2.3. Pre-analytical management: sample collection, preservatives, storage of post-mortem specimens, preparation and extraction. 1.2.4 Calibration in the case of post-mortem specimens. 1.2.5. Standards for post-mortem screening and confirmatory analytical methods. 1.2.6. Analytical methods for new psychoactive substances in post-mortem specimens. 1.2.7. Interpretation and reporting of findings in forensic toxicology. 1.2.8. Certification of drug-related deaths. 1.3. Discussion. Part 2: Survey of practices — mapping the ‘typical’ or ‘standard’ toxicology practices in place in each country. 2.1. Objective. 2.2. Methods. 2.3. Results. 2.3.1 Characteristics of participating laboratories. 2.3.2. Collection of test material for toxicological analysis. 2.3.3. Laboratory equipment. 2.3.4. Analytical strategy. 2.3.5. Analytical strategy: classification. 2.3.6. Special analytical considerations and reporting. 2.3.7. Substance group coverage. 2.3.8. Collaboration/information Exchange. 2.3.9. Coverage of new psychoactive substances. 2.3.10. Suggestions for improvements. 3. Discussion and conclusions. 3.1 Interpreting drug-related death prevalence data against the background of toxicology standards and capacity in European countries. 3.2. Conclusions. 3.2.1. Consequences and priorities for public health. References.
606			_aTOXICOLOGIA FORENSE _9100154
606			_aANÁLISE LABORATORIAL _9326721
606			_aANÁLISE DE VESTÍGIOS _9320649
606			_aTOXICODEPENDÊNCIA _9225048
606			_aEUROPA _9326972
710			_aEUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION _9351987
955			_xOferta